Alpha Tau Medical Ltd.

NASDAQ:DRTS

3.1 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -29.157-33.762-27.271-8.882-8.464
Depreciation & Amortization 1.0740.9790.7760.0860.066
Deferred Income Tax -8.931013.2570.2030.994
Stock Based Compensation 7.9266.7480.8120.5960.546
Change In Working Capital 2.492-0.3070.5850.899-0.064
Accounts Receivables 00000
Inventory 00000
Accounts Payables 1.1430.220.2390.1140.148
Other Working Capital 1.349-0.5270.3460.785-0.212
Other Non Cash Items 8.6382.4630.029-0.1530.012
Operating Cash Flow -17.958-23.879-11.812-7.251-6.91
Investing Activities:
Investments In Property Plant And Equipment -6.401-0.904-2.927-3.767-1.293
Acquisitions Net -28.235-22.2-22.200.009
Purchases Of Investments -163.629-121.137-8.082-4.05-54.27
Sales Maturities Of Investments 191.86432.10530.28266.1545.4
Other Investing Activites 25.08322.222.2-66.15-0.009
Investing Cash Flow 18.682-89.93619.273-7.817-10.163
Financing Activities:
Debt Repayment 5.2480000
Common Stock Issued 0.0493.3620.11129.3175.25
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities 0.04996.9050.11129.3170.073
Financing Cash Flow 5.29796.9050.11129.3175.323
Other Information:
Effect Of Forex Changes On Cash -0.05-0.2580.1080.084-0.018
Net Change In Cash 5.971-17.1687.6814.333-11.768
Cash At End Of Period 12.6576.68623.85416.1741.841